Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I would not be surprised if the FDA pulled an AMARIN on them and said o.k. lets wait on the 390 trial.
How much can CYDY match in political contributions against BP.
The question that needs to be asked, is - Does the agreement give Vyera the right to price leronlimab ?
As you may know, Vyera was the vehicle of Martin Shkreli, who is well known for raising the price of drugs under his control.
Vyera is now under the umbrella of Phoenixus.
https://www.thedailybeast.com/martin-shkreli-still-running-his-drug-company-phoenixus-ag-from-behind-bars-report
Martin Shkreli, the disgraced pharmaceutical executive, continues to run his company from prison with the help of a contraband cellphone, The Wall Street Journal reports. Shkreli was sentenced to seven years in prison last year for defrauding investors in his hedge funds and for manipulating the stock of his pharmaceutical company. The company, Phoenixus AG, brought to light the industry-wide practice of hiking up the prices of rare drugs. Shkreli jacked up the price of one HIV drug from $13.50 to $750. The so-called “pharma bro” recently fired his handpicked chief executive over the phone while he was on vacation, according to a source familiar with the exchange.
Shkreli plans to emerge from jail richer than he entered. According to his own calculations, Phoenixus could be worth $3.7 billion by the time he is freed in 2023. For that to happen, Shkreli plans to acquire more rare drugs in various stages of development and invest in ambitious research and development. The incarcerated executive reportedly spends his time reading pharmaceutical research on the inmate computer lab or on his phone.
For a bit of history, wikipedia is a great read.
https://en.wikipedia.org/wiki/Vyera_Pharmaceuticals
Also see-
https://www.bloomberg.com/opinion/articles/2020-01-30/slapping-around-martin-shkreli-won-t-cut-drug-prices
https://www.cnbc.com/2019/04/24/pharma-bro-martin-shkreli-moved-from-prison-after-rule-breaking.html
July 31, $420
The Perilous Development Of A Potential Biologic Blockbuster
https://www.bioprocessonline.com/doc/the-perilous-development-of-a-potential-biologic-blockbuster-0001
There was a mention of $87 million in milestone payments - any idea what that is about ?
Since he's using other peoples money to finance his move into online gaming. That was the part that got to me. Got into LCAHU @$15.54 in the a.m. and got out at $17.00 in the p.m. Not looking at NKLA at all. May take a shot at SHLL. (On a visit to Toronto some years ago, I specifically went to Niagara Falls to see Tesla's statue. He is a hero.)
CytoDyn Bolts Higher On Mexican Approval Chatter
https://insiderfinancial.com/cytodyn-otcmkts-cydy-bolts-higher-on-mexican-approval-chatter/180087/
A possible clinical trial participant.
Suggest you check with your broker. I bought the units yesterday, and when I called TD to have them split into the stock and the warrants, I was told that I would not be able to trade the stock, so I kept the units, and sold after hours, made $7.2K.
What are your thoughts on LCAHW and LCAHU ?
After reading Marjac's post of the Reply Brief, and seeing all those defense references to Mori, Hayashi and Kurabayshi, all I could think of was Kobayshi Maru to the defense.
Basically, today is a non-event.
Squeaked in minutes before the halt, got another 5K @ $24.06
Thought what the heck that's $1 less that my Jan $25 options.
Judging from previous activity, I would not be at all surprised if the shorts got to cover at $26 to $27, i.e. a low orbital flight, not a moon shot.
Broke my No. 1 Ferenghi rule of acquisition - Do not buy a stock in both IRA and Trading account.
2019-11-14 13F PERCEPTIVE ADVISORS LLC 7,636,079 115,763,
Under what name(s) are these shares held ?
From LinkedIn
Leland Gershell
Managing Director
Madison Williams and Company
May 2011 – Apr 2012 1 year
MADISON WILLIAMS AND COMPANY
(MADISON WILLIAMS AND COMPANY,MADISON WILLIAMS AND COMPANY LLC,SIWANOY SECURITIES, LLC)
CRD#: 149530/SEC#: 8-68150
PR Previously Registered Brokerage Firm
FINRA cancelled this firm's license in January 2012.
Not currently registered as broker
I would consider this a year of life wasted.
Chief Financial Officer
Tonix Pharmaceuticals
Apr 2012 – Jan 2016 3 years 10 months
New York, NY
Current Market Cap $2.32M
Chief Financial Officer
Capricor Therapeutics, Inc.
Feb 2016 – Jan 2018 2 years
New York, NY
Current Market Cap $7.303M
Seems like quite a chequered career.
Latest figures on Fintel.io
2019-11-14 13F Invesco Ltd. 8,416,245
2019-10-31 13F OPPENHEIMER & CO INC 27,779
2019-10-31 13F OPPENHEIMER ASSET MANAGEMENT INC. 11,265
2019-11-14 13F Baker Brothers Advisors LP 41,544,288
The original price was $32,000.00
According to their website, they were -
"Founded in March of 2019, Medical Research Collaborative, LLC"
and on Ihub, Alias Born 01/18/2019 08:37:13 AM
One has to wonder what kind of slimy gets a posting account before the company is founded.
While there is a Florida address, I could not find them registered with the Florida Secretary of State.
Then perhaps you can get him to tell me that an article on taxation is political.
Large holders added 15,567,592 shares during the first quarter.
https://www.holdingschannel.com/top/
Does anyone know how this compares to ADVM's ADVM-053, in terms of time to approval and time to market ?? ??
Certainly something to keep in mind, if the trials do not meet their targets. Cronos is in partnership with GinkoBio Works, and Organigram with Hyacinth.
TD has unconfirmed June 27.
Strike ?
Las Vegas man 1st in world to use new experimental cancer drug, ARV 101.
https://www.reviewjournal.com/life/health/las-vegas-man-1st-in-world-to-use-new-experimental-cancer-drug-video-1654750/